Tie2 protects the vasculature against thrombus formation in systemic inflammation
View abstract on PubMed
Summary
This summary is machine-generated.Disrupted Tie2 signaling drives septic disseminated intravascular coagulation (DIC). Targeting Tie2 may offer new treatments for sepsis-induced coagulation disorders without increasing bleeding risk.
Area Of Science
- Vascular Biology
- Coagulation Science
- Sepsis Pathophysiology
Background
- Disordered coagulation in sepsis leads to high mortality.
- Current disseminated intravascular coagulation (DIC) markers are reactive, delaying diagnosis and treatment.
Purpose Of The Study
- To investigate the role of the endothelial Tie2 axis in septic DIC.
- To identify novel biomarkers and therapeutic targets for septic DIC.
Main Methods
- Proteomic analysis in septic DIC patients.
- Association studies with traditional DIC markers and mortality.
- In vivo studies in endotoxemic mice using intravital imaging.
- Assessment of Tie2 activation effects on coagulation and bleeding.
Main Results
- Angiopoietin-2 (Angpt-2), a Tie2 antagonist, is central in septic DIC and predicts mortality.
- Reduced Tie2 signaling precedes overt DIC in mice, causing excessive fibrin accumulation.
- Tie2 activation inhibits prothrombotic endothelial responses and does not increase bleeding.
Conclusions
- Tie2 signaling is a critical regulator of microvascular thrombus formation in septic DIC.
- Circulating Tie2 axis markers could enable earlier DIC diagnosis.
- Tie2-targeting interventions may treat sepsis-induced coagulation abnormalities safely.